Outsourcing facilities regulated under Section 503B under the Federal Food, Drug, and Cosmetic Act
2025 · 4th Quarter (Oct 1 - Dec 31)
QUVA PHARMA, INC.
Filed by VAN SCOYOC ASSOCIATES.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 19, 2026
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- VAN SCOYOC ASSOCIATES
- Client
- QUVA PHARMA, INC.
- Filing UUID
- a5c34f9f-8dab-4c6c-9c87-c5c6eabc9304
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.